The advent of anti-TNF-α therapies has revolutionized IBD management by neutralizing this cytokine’s effects, reducing the infiltration of inflammatory immune cells, and promoting mucosal healing [39,40] (Figure 1). Here, TNF is linked to inflammatory bowel disease.